Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 86,450 | 78,336 | 85,299 | 80,412 | 70,273 |
| Operating Income | -86,450 | -78,336 | -85,299 | -80,412 | -70,273 |
| Interest Expense | 2,901 | 2,336 | 1,682 | 1,502 | 780 |
| Other Income | 3,551 | 3,776 | 1,076 | 717 | 323 |
| Pre-tax Income | -85,800 | -76,896 | -85,905 | -81,197 | -70,730 |
| Net Income Continuous | -85,800 | -76,896 | -85,905 | -81,197 | -70,730 |
| Net Income | $-85,800 | $-76,896 | $-85,905 | $-81,197 | $-70,730 |
| EPS Basic Total Ops | -4.69 | -4.23 | -4.98 | -4.75 | -4.14 |
| EPS Basic Continuous Ops | -4.69 | -4.23 | -4.99 | -4.75 | -4.14 |
| EPS Diluted Total Ops | -4.69 | -4.23 | -4.98 | -4.75 | -4.14 |
| EPS Diluted Continuous Ops | -4.69 | -4.23 | -4.99 | -4.75 | -4.14 |
| EBITDA(a) | $-85,770 | $-77,779 | $-84,864 | $-79,978 | $-69,985 |